Dare Bioscience Return On Equity vs. Operating Margin
| DARE Stock | USD 2.11 0.08 3.94% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.00067431 | Current Value 0.000708 | Quarterly Volatility 10.6768997 |
For Dare Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dare Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dare Bioscience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dare Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dare Bioscience over time as well as its relative position and ranking within its peers.
Check out Investing Opportunities. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.17) | Revenue Per Share | Quarterly Revenue Growth 1.734 | Return On Assets | Return On Equity |
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dare Bioscience Operating Margin vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Dare Bioscience's current stock value. Our valuation model uses many indicators to compare Dare Bioscience value to that of its competitors to determine the firm's financial worth. Dare Bioscience is rated below average in return on equity category among its peers. It is rated # 4 in operating margin category among its peers . At present, Dare Bioscience's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Dare Bioscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Dare Operating Margin vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Dare Bioscience |
| = | -9.95 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Dare Bioscience |
| = | (180.17) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Dare Operating Margin Comparison
Dare Bioscience is currently under evaluation in operating margin category among its peers.
Dare Bioscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Dare Bioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dare Bioscience will eventually generate negative long term returns. The profitability progress is the general direction of Dare Bioscience's change in net profit over the period of time. It can combine multiple indicators of Dare Bioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -428.8 M | -407.4 M | |
| Operating Income | -23.5 M | -24.6 M | |
| Income Before Tax | -4.1 M | -4.3 M | |
| Total Other Income Expense Net | 19.4 M | 12.1 M | |
| Net Loss | -4.1 M | -4.3 M | |
| Income Tax Expense | -4 B | -3.8 B | |
| Net Loss | -4.1 M | -4.3 M | |
| Non Operating Income Net Other | 1.7 K | 1.8 K | |
| Net Loss | -27.9 M | -29.2 M | |
| Interest Income | 290.4 K | 275.8 K | |
| Net Interest Income | -371 K | -389.6 K | |
| Change To Netincome | 1.1 M | 1 M | |
| Net Loss | (0.48) | (0.50) | |
| Income Quality | (1.33) | (1.26) | |
| Net Income Per E B T | 1.14 | 1.11 |
Dare Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Dare Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dare Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dare Bioscience's important profitability drivers and their relationship over time.
Use Dare Bioscience in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dare Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dare Bioscience will appreciate offsetting losses from the drop in the long position's value.Dare Bioscience Pair Trading
Dare Bioscience Pair Trading Analysis
The ability to find closely correlated positions to Dare Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dare Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dare Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dare Bioscience to buy it.
The correlation of Dare Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dare Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dare Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dare Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Dare Bioscience position
In addition to having Dare Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Sovereign ETFs Thematic Idea Now
Broad Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Sovereign ETFs theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
To fully project Dare Bioscience's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Dare Bioscience at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Dare Bioscience's income statement, its balance sheet, and the statement of cash flows.